Please wait

Exhibit 107

Calculation of Filing Fee Tables

424(b)(5)

(Form Type)

Disc Medicine, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                 
      Security
Type		    Security
Class
Title		    Fee Calculation
or Carry
Forward
Rule		    Amount
Registered		    Proposed
Maximum
Offering
Price
Per Unit		    Maximum
Aggregate
Offering Price		    Fee Rate    Amount of
Registration
Fee
Newly Registered Securities
                 
Fees to Be Paid    Equity    Common Stock,
$0.0001

par value
per share

    457(o) and 457(r)(1)    $200,000,000    —    $200,000,000    0.00015310    $30,620
                 

Fees Previously

Paid

    —    —    —    —    —    —    —    —
                 
           Total Offering Amounts          $200,000,000       $30,620
                 
           Total Fees Previously Paid                —
                 
           Total Fee Offsets                $25,144.84(2)
               
          Net Fee Due                        $5,475.16

 

(1)

The registration fee is calculated in accordance with Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”), based on the proposed maximum aggregate offering price, and Rule 457(r) under the Securities Act. In accordance with Rules 456(b) and 457(r) under the Securities Act, the Registrant initially deferred payment of all of the registration fee for Registration Statement on Form S-3ASR (Registration No. 333-281359), which was filed with the Securities and Exchange Commission (the “SEC”) on August 8, 2024.

(2)

Pursuant to Rule 457(p) under the Securities Act, the registrant hereby applies $25,144.84 of the registration fee previously paid in connection with the Prior Registration Statement (as defined below) to offset the registration fees that are payable in connection with the registration of securities on this registration statement.

Table 2: Fee Offset Claims and Sources

 

                       
     

Registrant
or Filer

Name

    Form
of
Filing
Type		   

File

Number

   

Initial

Filing

Date

   

Filing

Date

   

Fee

Offset

Claimed

    Security
Type
Associated
with Fee
Offset
Claimed		    Security
Title
Associated
with Fee
Offset
Claimed		    Unsold
Securities
Associated
with Fee
Offset
Claimed		   

Unsold

Aggregate

Offering

Amount

Associated

with Fee

Offset

Claimed

   

Fee

Paid

with

Fee

Offset

Source

 
Newly Registered Securities
                       

Fee Offset

Claims

    Disc Medicine, Inc.    S-3    333-275652    November 20, 2023       $25,144.84    Equity    Common Stock    (3)    $170,357,981.13     
                       

Fee Offset

Sources

    Disc Medicine, Inc.    S-3    333-275652         November 20, 2023                             $25,144.84

 

(3)

On November 20, 2023, the registrant filed a registration statement on Form S-3 (File No. 333-275652) (the “Prior Registration Statement”) and on December 5, 2023, the registrant filed a prospectus supplement in connection with its 2023 “at-the-market” offering program (the “2023 ATM Prospectus”). The registrant paid a filing fee in the amount of $59,040.00 to register shares of its common stock with a maximum aggregate offering price of $400,000,000, which fee was calculated pursuant to Rule 457(o) under the Securities Act. As of the termination of the offering made pursuant to the 2023 ATM Prospectus $170,357,981.13 of shares of the registrant’s common stock remained unsold. Pursuant to Rule 457(p) under the Securities Act, filing fees in the amount of $25,144.84 relating to the unsold securities are being carried forward.